ATE341310T1 - Dehydratisierungs-/rehydratisierungsverfahren zur herstellung von liposome - Google Patents

Dehydratisierungs-/rehydratisierungsverfahren zur herstellung von liposome

Info

Publication number: ATE341310T1
Authority: AT; Austria
Prior art keywords: sugar; dehydration; lipid; liposomes; rehydration
Prior art date: 2000-02-04

Application number

AT01948934T

Other languages

English (en)

Inventor

Brahim Zadi

Original Assignee

Lipoxen Technologies Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-04

Filing date

2001-01-31

Publication date

2006-10-15

2001-01-31 Application filed by Lipoxen Technologies Ltd filed Critical Lipoxen Technologies Ltd

2006-10-15 Application granted granted Critical

2006-10-15 Publication of ATE341310T1 publication Critical patent/ATE341310T1/de

Links

239000002502 liposome Substances 0.000 title abstract 4
230000018044 dehydration Effects 0.000 title 1
238000006297 dehydration reaction Methods 0.000 title 1
238000000034 method Methods 0.000 title 1
239000004480 active ingredient Substances 0.000 abstract 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
229940079593 drug Drugs 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 2
150000002632 lipids Chemical class 0.000 abstract 2
229930012538 Paclitaxel Natural products 0.000 abstract 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
229930006000 Sucrose Natural products 0.000 abstract 1
-1 anionic lipid Chemical class 0.000 abstract 1
235000012000 cholesterol Nutrition 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
229960001592 paclitaxel Drugs 0.000 abstract 1
WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 abstract 1
239000005720 sucrose Substances 0.000 abstract 1
RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
- A61K9/1278—Post-loading, e.g. by ion or pH gradient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Dispersion Chemistry (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Hematology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Manufacturing Of Micro-Capsules (AREA)

AT01948934T 2000-02-04 2001-01-31 Dehydratisierungs-/rehydratisierungsverfahren zur herstellung von liposome ATE341310T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP00300904		2000-02-04

Publications (1)

Publication Number	Publication Date
ATE341310T1 true ATE341310T1 (de)	2006-10-15

Family

ID=8172682

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01948934T ATE341310T1 (de)	2000-02-04	2001-01-31	Dehydratisierungs-/rehydratisierungsverfahren zur herstellung von liposome

Country Status (8)

Country	Link
US (1)	US7025988B2 (de)
EP (1)	EP1259225B1 (de)
JP (1)	JP4786105B2 (de)
AT (1)	ATE341310T1 (de)
AU (1)	AU2869901A (de)
DE (1)	DE60123583T2 (de)
ES (1)	ES2272496T3 (de)
WO (1)	WO2001056548A2 (de)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2456746A1 (en) *	2001-08-20	2003-02-27	Transave, Inc.	Method for treating lung cancers
CN101134119A (zh)	2002-05-24	2008-03-05	血管技术国际股份公司	用于涂覆医用植入物的组合物和方法
EP1530465B2 (de)	2002-06-26	2015-12-16	MediGene AG	Herstellung einer kationisch liposomalen zubereitung, einen lipophilen wirkstoff enthaltend
US7604803B2 (en)	2002-07-05	2009-10-20	Lipoxen Technologies Limited	Method to enhance an immune response of nucleic acid vaccination
EP1545459A4 (de) *	2002-08-02	2007-08-22	Transave Inc	Platinaggregate und verfahren zu ihrer herstellung
US9186322B2 (en) *	2002-08-02	2015-11-17	Insmed Incorporated	Platinum aggregates and process for producing the same
US20050255164A1 (en) *	2002-08-15	2005-11-17	Yunging Liu	Solid nano pharmaceutical formulation and preparation method thereof
US7879351B2 (en) *	2002-10-29	2011-02-01	Transave, Inc.	High delivery rates for lipid based drug formulations, and methods of treatment thereof
US7718189B2 (en)	2002-10-29	2010-05-18	Transave, Inc.	Sustained release of antiinfectives
EA200501285A1 (ru) *	2003-02-11	2006-02-24	Неофарм, Инк.	Способ получения липосомальных препаратов
JP2007522085A (ja) *	2003-06-27	2007-08-09	スミスクライン・ビーチャム・コーポレイション	安定化されたトポテカンリポソーム組成物および方法
US20050048109A1 (en) *	2003-08-26	2005-03-03	Ceramoptec Industries, Inc.	Non-polar photosensitizer formulations for photodynamic therapy
CA2559722A1 (en) *	2004-03-18	2005-09-29	Transave, Inc.	Administration of cisplatin by inhalation
US20070065522A1 (en) *	2004-03-18	2007-03-22	Transave, Inc.	Administration of high potency platinum compound formulations by inhalation
LT3173073T (lt)	2004-05-03	2025-01-10	Ipsen Biopharm Ltd.	Liposomos, skirtos vaistų pristatymui
US8658203B2 (en)	2004-05-03	2014-02-25	Merrimack Pharmaceuticals, Inc.	Liposomes useful for drug delivery to the brain
WO2005112957A1 (en) *	2004-05-21	2005-12-01	Transave, Inc.	Treatment of lung diseases and pre-lung disease conditions
US20050281739A1 (en) *	2004-06-16	2005-12-22	Glen Gong	Imaging damaged lung tissue using compositions
US7678767B2 (en)	2004-06-16	2010-03-16	Pneumrx, Inc.	Glue compositions for lung volume reduction
US20050281798A1 (en) *	2004-06-16	2005-12-22	Glen Gong	Targeting sites of damaged lung tissue using composition
US7553810B2 (en) *	2004-06-16	2009-06-30	Pneumrx, Inc.	Lung volume reduction using glue composition
US7468350B2 (en)	2004-06-16	2008-12-23	Pneumrx, Inc.	Glue composition for lung volume reduction
US7608579B2 (en) *	2004-06-16	2009-10-27	Pneumrx, Inc.	Lung volume reduction using glue compositions
US20050281740A1 (en) *	2004-06-16	2005-12-22	Glen Gong	Imaging damaged lung tissue
CA2570261C (en)	2004-07-08	2014-06-10	Pneumrx, Inc.	Pleural effusion treatment device, method and material
MX2007004955A (es) *	2004-11-08	2007-06-14	Transave Inc	Metodo de tratar cancer con formulaciones de compeusto de platino a base de lipido administradas intraperitonealmente.
US8916197B2 (en)	2005-06-06	2014-12-23	The Board Of Regents Of The University Of Texas System	Bone marrow-directing drug delivery materials and their applications
TWI291237B (en) *	2005-10-07	2007-12-11	Integrated Digital Technologie	Photo detector array
US20070190182A1 (en) *	2005-11-08	2007-08-16	Pilkiewicz Frank G	Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
US9107824B2 (en)	2005-11-08	2015-08-18	Insmed Incorporated	Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
US20070190181A1 (en) *	2005-11-08	2007-08-16	Pilkiewicz Frank G	Methods of treating cancer with lipid-based platinum compound forumulations administered intravenously
EP3067047B1 (de)	2005-12-08	2022-04-20	Insmed Incorporated	Antiinfektive zusammensetzungen auf lipidbasis zur behandlung von lungeninfekten
EP2012750B1 (de) *	2006-04-06	2018-02-21	Insmed Incorporated	Verfahren für koazervationsinduzierte liposomale verkapselung und formulierungen daraus
WO2008036763A2 (en) *	2006-09-20	2008-03-27	Pneumrx, Inc.	Tissue adhesive compositions and methods thereof
WO2008137717A1 (en)	2007-05-04	2008-11-13	Transave, Inc.	Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
US9119783B2 (en)	2007-05-07	2015-09-01	Insmed Incorporated	Method of treating pulmonary disorders with liposomal amikacin formulations
US9333214B2 (en)	2007-05-07	2016-05-10	Insmed Incorporated	Method for treating pulmonary disorders with liposomal amikacin formulations
US9114081B2 (en)	2007-05-07	2015-08-25	Insmed Incorporated	Methods of treating pulmonary disorders with liposomal amikacin formulations
US9445975B2 (en)	2008-10-03	2016-09-20	Access Business Group International, Llc	Composition and method for preparing stable unilamellar liposomal suspension
US9006280B2 (en) *	2008-11-20	2015-04-14	Teikoku Pharma Usa, Inc.	Pyrazolone derivative formulations
US20110070294A1 (en) *	2009-09-23	2011-03-24	Javeri Indu	Methods for the Administration of Drugs Using Liposomes
CA2781527C (en) *	2009-09-23	2017-10-24	Indu Javeri	Methods for the preparation of liposomes
US10143652B2 (en)	2009-09-23	2018-12-04	Curirx Inc.	Methods for the preparation of liposomes
EP2394640A1 (de) *	2010-05-21	2011-12-14	MediGene AG	Verbesserte liposomale Formulierungen von lipophilen Verbindungen
PL2852391T3 (pl)	2012-05-21	2022-04-11	Insmed Incorporated	Układy do leczenia infekcji płuc
US9717724B2 (en)	2012-06-13	2017-08-01	Ipsen Biopharm Ltd.	Methods for treating pancreatic cancer using combination therapies
AU2013202947B2 (en)	2012-06-13	2016-06-02	Ipsen Biopharm Ltd.	Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
EP2682106A1 (de)	2012-07-03	2014-01-08	Phares Pharmaceutical Research N.V.	Verfahren zum Auflösen biologisch aktiver Verbindungen
WO2014034669A1 (ja) *	2012-08-28	2014-03-06	国立大学法人北海道大学	非極性溶媒に分散性を有する細菌菌体成分を内封する脂質膜構造体およびその製造方法
DK2892524T3 (da)	2012-09-04	2021-01-25	Eleison Pharmaceuticals LLC	Forebyggelse af pulmonalt kræfttilbagefald med lipid-komplekseret cisplatin
US10124066B2 (en)	2012-11-29	2018-11-13	Insmed Incorporated	Stabilized vancomycin formulations
LT3466432T (lt)	2014-05-15	2020-12-28	Insmed Incorporated	Būdai, skirti plaučių netuberkuliozinėms mikobakterinėms infekcijoms gydyti
US11318131B2 (en)	2015-05-18	2022-05-03	Ipsen Biopharm Ltd.	Nanoliposomal irinotecan for use in treating small cell lung cancer
JP7042739B2 (ja)	2015-08-20	2022-03-28	イプセンバイオファームリミティド	癌処置のためのリポソーム型イリノテカン及びｐａｒｐ阻害薬を使用する併用療法
TW202400181A (zh)	2015-08-21	2024-01-01	英商益普生生物製藥有限公司	使用包含微脂伊立替康(irinotecan)及奧沙利鉑(oxaliplatin)之組合療法治療轉移性胰臟癌的方法
EP4647126A3 (de)	2015-10-16	2026-02-11	Ipsen Biopharm Ltd.	Stabilisierung von pharmazeutischen camptothecinzusammensetzungen
CN106924195B (zh) *	2015-12-31	2020-11-13	南京绿叶制药有限公司	一种注射用紫杉醇脂质体组合物的冻干工艺
CN108136217B (zh) *	2016-01-07	2021-04-30	健康科学西部大学	用于治疗膀胱癌的制剂
US10874733B2 (en)	2016-10-31	2020-12-29	Eyegene Inc.	Composition for enhancing immunity comprising immune modulator and cationic liposome, and use of same
CN110402163A (zh)	2016-11-02	2019-11-01	易普森生物制药有限公司	使用包括脂质体伊立替康、奥沙利铂、5-氟尿嘧啶(和甲酰四氢叶酸)的组合疗法治疗胃癌
EP3773505B1 (de)	2018-03-30	2026-04-29	Insmed Incorporated	Verfahren zur kontinuierlichen herstellung von liposomalen arzneimittelprodukten
JP7449275B2 (ja)	2018-05-02	2024-03-13	インスメッドインコーポレイテッド	リポソーム薬物製剤の製造方法
CN120115020B (zh) *	2025-04-01	2026-03-03	华北理工大学	一种疏水仿生膜及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4880635B1 (en)	1984-08-08	1996-07-02	Liposome Company	Dehydrated liposomes
US4885172A (en)	1985-06-26	1989-12-05	The Liposome Company, Inc.	Composition for targeting, storing and loading of liposomes
US4766046A (en) *	1985-09-27	1988-08-23	Liposome Technology, Inc.	Stabilized liposome/amphotericin composition and method
FR2593394A1 (fr) *	1986-01-30	1987-07-31	Ire Celltarg Sa	Procede de preparation de liposomes contenant une subtance active lipophile, notamment de l'amphotericine, liposomes et nouveau medicament obtenus
WO1994026254A1 (en)	1993-05-17	1994-11-24	The Liposome Company, Inc.	Incorporation of taxol into liposomes and gels
GB9320668D0 (en) *	1993-10-07	1993-11-24	Secr Defence	Liposomes containing particulare materials
US5415869A (en) *	1993-11-12	1995-05-16	The Research Foundation Of State University Of New York	Taxol formulation
DE4432378A1 (de)	1994-09-12	1996-03-14	Bayer Ag	Injizierbare liposomale Arzneizubereitungen
DE69528077T2 (de) *	1994-11-18	2003-04-17	Aphios Corp., Woburn	Verfahren zur Herstellung von Liposomen, die hydrophobische Artzneistoffe enthalten
GB9813100D0 (en)	1998-06-18	1998-08-19	Secr Defence	Method of forming liposomes
US6146659A (en) *	1998-07-01	2000-11-14	Neopharm, Inc.	Method of administering liposomal encapsulated taxane

2001
- 2001-01-31 DE DE60123583T patent/DE60123583T2/de not_active Expired - Lifetime
- 2001-01-31 AT AT01948934T patent/ATE341310T1/de not_active IP Right Cessation
- 2001-01-31 JP JP2001556240A patent/JP4786105B2/ja not_active Expired - Fee Related
- 2001-01-31 ES ES01948934T patent/ES2272496T3/es not_active Expired - Lifetime
- 2001-01-31 US US10/182,921 patent/US7025988B2/en not_active Expired - Fee Related
- 2001-01-31 AU AU28699/01A patent/AU2869901A/en not_active Abandoned
- 2001-01-31 EP EP01948934A patent/EP1259225B1/de not_active Expired - Lifetime
- 2001-01-31 WO PCT/GB2001/000391 patent/WO2001056548A2/en not_active Ceased

Also Published As

Publication number	Publication date
US7025988B2 (en)	2006-04-11
DE60123583T2 (de)	2007-08-09
EP1259225A2 (de)	2002-11-27
AU2869901A (en)	2001-08-14
EP1259225B1 (de)	2006-10-04
ES2272496T3 (es)	2007-05-01
WO2001056548A3 (en)	2002-03-21
US20030138481A1 (en)	2003-07-24
JP2003521508A (ja)	2003-07-15
WO2001056548A2 (en)	2001-08-09
JP4786105B2 (ja)	2011-10-05
DE60123583D1 (de)	2006-11-16

Legal Events

Date	Code	Title	Description
2007-04-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE341310T1 (de)	2006-10-15	Dehydratisierungs-/rehydratisierungsverfahren zur herstellung von liposome
EP0277776A3 (de)	1989-09-27	Liposome mit harten Kernen
US5262168A (en)	1993-11-16	Prostaglandin-lipid formulations
US5082664A (en)	1992-01-21	Prostaglandin-lipid formulations
TW359616B (en)	1999-06-01	A parenterally administered pharmaceutical composition for lipophilic, poorly soluble active compounds, in the form of liposomes with phospholipid membranes
NZ334561A (en)	2000-01-28	Preparation of multivesicular liposomes for controPreparation of multivesicular liposomes for controlled release of active agents lled release of active agents
WO1999016426A3 (en)	1999-06-17	Multilamellar coalescence vesicles (mlcv) containing biologically active compounds
AU6036596A (en)	1996-12-30	Process for making liposome preparation
NZ508960A (en)	2002-11-26	Method of forming liposomes
KR880001284A (ko)	1988-04-22	단일 이중층 리포좀의 제조방법
DK0560138T3 (da)	1996-08-05	Liposomale præparater af virksomt stof og fremgangsmåde til deres fremstilling
FR2634375B3 (fr)	1991-07-05	Procede de preparation de systemes colloidaux dispersibles de lipide amphiphiles sous forme de liposomes submicroniques
CA2488124A1 (en)	2003-12-18	Vitamin a liposomes and the method of its preparation
HUT62457A (en)	1993-05-28	Process for producing aqueous liposomal suspensions comprising an active ingredient
EP0198765A3 (de)	1987-10-21	Herstellung von Liposomen
WO2003026617A3 (de)	2003-10-09	(ester)-lysolecithine in liposomen
DE59914774D1 (de)	2008-07-10	Verfahren zur herstellung von liposomalen wirkstoffformulierungen
CA2177696A1 (en)	1995-06-22	Lipid vesicles containing avocado oil unsaponifiables
UENO et al.	2000	Interaction of liposomes with detergents
UA6700C2 (uk)	1994-12-29	Спосіб одержання липосомальної форми протипухлинного антибіотика
Matveev et al.	1994	Preparation of liposomes from yeast phospholipids
CA2050971A1 (en)	1993-03-10	Liposomal delivery system with photoactivatable triggered release
ATE308975T1 (de)	2005-11-15	Dinitroanilin enthaltende liposomen und verfahren zur herstellung derselben
HK1007496B (en)	1999-04-16	Prostaglandin-lipid formulations